Oxford Global’s R&D Key 40 Stories 2022

26 October 2022
Download a copy of the R&D Key 40 Stories 2022 ebook today. 

We are pleased to share with you selected highlights from Oxford Global’s content portfolios that we have been building over the past few years. In this ebook, a culmination of our efforts, we are delighted to present a variety of the most successful and widely read pieces we have released this year, providing you with invaluable insights into using CAR T cell therapy for treating solid tumours, the link between gut bacteria and the efficacy of ICIs, and biomarker diagnostics in immuno-oncology. 

Sample (click to enlarge)

To read the ebook in full, please click below to launch our immersive ebook reader

How would you rate this content?

Share this article

Sign up for our monthly Immuno Newsletter

You may also be interested in...

Industry Spotlight
Diving deep into Lokon Pharma's immunostimulatory oncolytic virus programme. Learn about their LOAd platform, transition to the clinic, and more.
14 November 2023
Industry Spotlight
Explore the cutting-edge of oncolytic virus immunotherapy in immuno-oncology: the viruses revolutionizing cancer treatment and the promise they hold for future therapies.
14 November 2023

Continue browsing

Share this article

Join our Immuno mailing list

Stay up to date

Sign up for our monthly Editorial Newsletter to keep up with all things Immuno